Aegerion Pharmaceuticals, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 102   

Articles published

AEGR 17.21 -0.48 (-2.71%)
price chart
Aegerion Pharmaceuticals, Inc. Analyst Rating Update
Research firm Zacks has rated Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) and has ranked it at 3, indicating that for the short term the shares are a hold.
Stock in Focus - Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR)  Vanguard Tribune
Company Shares of Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) Drops by -3.29%
Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) has lost 3.29% during the past week and dropped 7.68% in the last 4 weeks.
Shares of Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) Sees Large Inflow of ...
Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) saw its share price trade relatively negative in the recent trading session.
Jefferies Upgrades Aegerion Pharma To Buy, Sees Positively Skewed Risk/Reward
In a report published Tuesday, Jefferies analyst Eun K. Yang upgraded the rating on Aegerion Pharmaceuticals, Inc. (NASDAQ: AEGR) from Hold to Buy, while maintaining the price target at $26.
Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR)announced that Aegerion board ...  Inside Trade
Earnings Scope: Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR)  Markets Daily
Why Aegerion Pharmaceuticals, Inc. Stock Collapsed in October
What: Shares of Aegerion Pharmaceuticals (NASDAQ: AEGR ) , a biopharmaceutical company focused on developing drugs to treat rare diseases, collapsed in October and lost 40% of their value, based on data from S&P Capital IQ, after the company ...
Aegerion Pharmaceuticals (AEGR) to Acquire Myalept from AstraZeneca (AZN ...  StreetInsider.com (subscription)
Aegerion Pharma Buys Drug From AstraZeneca for $325M  Mergers & Acquisitions - The Middle Market
Related articles »  
Shares of Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) Rally 1.56%
Shares of Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) rose by 1.56% in the past week and 4.34% for the last 4 weeks.
Aegerion Pharmaceuticals, Inc. Short Interest Update
Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) ensharesed a rise of 11.4% or 747,879 shares in the short positions. The number escalated from 6,590,189 on July 31,2015 to 7,338,068 on August 14,2015.
Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) Given $21-$107 PT Range  Markets Daily
Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) Analyst Rating in Focus  Investor Newswire
Aegerion Pharmaceuticals Inc. (AEGR) Drops 6.74% on August 24
Aegerion Pharmaceuticals Inc. (AEGR) was one of the Russell 2000's biggest losers for Monday August 24 as the stock slid 6.74% to $17.03, a loss of $-1.23 per share.
Aegerion Pharmaceuticals (AEGR) Flagged As Strong On High Volume
Aegerion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapies for patients with debilitating rare diseases in the United States.
Aegerion Pharmaceuticals, Inc. Price Target Update  News Watch International
Is Aegerion Pharmaceuticals Inc (NASDAQ:AEGR) a Good Investment?
[Globe Newswire] Aegerion Pharmaceuticals Inc (NASDAQ:AEGR)(TREND ANALYSIS) announced that on August 3, 2015, Aegerion granted stock options to purchase an aggregate of 283,325 shares of common stock to nine new employees under the ...